Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. Pylori-negative healthy subjects

Digestive Diseases and Sciences

Volumn 42, Issue 11, 1997, Pages 2304-2309

  Gan, K H ^b   Geus, W P ^a   Lamers, C B H W ^b   Heijerman, H G M ^b  

^a LEYENBURG HOSPITAL   (Netherlands)

^b NONE

Author keywords

Duodenum; Gastric acid secretion; Gastric acidity determination; Hydrogen ion concentration; Omeprazole

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OMEPRAZOLE; PLACEBO; PROTON PUMP;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENZYME ACTIVATION; FEMALE; GASTRITIS; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH PH; STOMACH SECRETION; ZOLLINGER ELLISON SYNDROME;

ADULT; ANTI-ULCER AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DUODENUM; FEMALE; GASTRIC ACIDITY DETERMINATION; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OMEPRAZOLE; STOMACH;

EID: 0031469020     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018827003641     Document Type: Article

References (35)

1. Maton PN: Omeprazole. N Engl J Med 324:965-975, 1991
2. Walt RP, Gomes MD, Wood EC, Logan LH, Pounder RE: Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Educ) 287:12-14, 1983
3. Gustavsson S, Adami HO, Loof L, Nyberg A, Nyren O: Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet 2:124-125, 1983
4. Prichard PJ, Yeomans ND, Mihaly GW, Jones DB, Buckle PJ, Smallwood RA, Louis WJ: Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 88:64-69, 1985
5. Cederberg C, Rohss K, Lundborg P, Olbe L: Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects. Scand J Gastroenterol 28:179-184, 1993
6. Prewett EJ, Hudson M, Nwokolo CU, Sawyerr AM, Pounder RE: Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Gastroenterology 100:873-877, 1991
7. Hurlimann S, Abbuhl B, Inauen W, Halter F: Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 8:193-201, 1994
8. Fried M, Siegrist H, Frei R, Froehlich F, Duroux P, Thorens J, Blum A, Bille J, Gonvers JJ, Gyr K: Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 35:23-26, 1994
9. Nelis GF, Engelage AH, Samson G: Does long-term inhibition of gastric acid secretion with omeprazole lead to small intestinal bacterial overgrowth? Neth J Med 45:93-100, 1994
10. Gough A, Andrews D, Bacon PA, Emery P: Evidence of omeprazole-induced small bowel bacterial overgrowth in patients with scleroderma. Br J Rheumatol 34:976-977, 1995
11. Pounder RE: Degrees of acid suppression and ulcer healing: dosage considerations. Aliment Pharmacol Ther 5:5-13, 1991
12. Creutzfeldt W: Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders. Drug Saf 10:66-82, 1994
13. Heijerman HG, Lamers CB, Bakker W: Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med 114:200-201, 1991
14. Geus WP, Smout AJ, Kooiman JC, Lamers CB, Geus JW: Glass and antimony electrodes for long-term pH monitoring: A dynamic in vitro comparison. Eur J Gastroenterol Hepatol 7:29-35, 1995
15. Röhmel J, Merki HS, Wilder-Smith CH, Walt RP: Analysis and statistical evaluation of continuous pH recordings. Dig Dis 8(suppl 1):87-96, 1990
16. Vallot T, Elouaer-Blanc L, Garcia del Risco F, Mignon M, Vatier J, Bonfils S: Comment exprimer les résultats de pH-métrie gastrique sur 24 heures? Choix d'un mode d'expression chez 27 sujets sains. Gastroenterol Clin Biol 12:610-618, 1988
17. Rune SJ: pH in the human duodenum: Its physiological and pathophysiological significance. Digestion 8:261, 1973
18. Dutta SK, Russell RM, Iber FL: Influence of exocrine pancreatic insufficiency in the intraluminal pH of the proximal small intestine. Dig Dis Sci 24:529-534, 1979
19. Ovesen L, Bendtsen F, Tage-Jensen U, Pedersen NT, Gram BR, Rune SJ: Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 90:958-962, 1986
20. Gilbert J, Kelleher J, Littlewood JM, Evans DF: Ileal pH in cystic fibrosis. Scand J Gastroenterol Suppl 143:132-134, 1988
21. Youngberg CA, Berardi RR, Howatt WF, Hyneck ML, Amidon GL, Meyer JH, Dressman JB: Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 32:472-480, 1987
22. Borgström B, Dahlqvist A, Lundh G, Sjövall J: Studies of intestinal digestion and absorption in the human. J Clin Invest 36:1521-1536, 1957
23. Worning H, Müllertz S: pH and pancreatic enzymes in the human duodenum during digestion of a standard meal. Scand J Gastroent 1:268-283, 1966
24. Owyang C, Williams JA: Pancreatic secretion. In Textbook of Gastroenterology. T Yamada (ed). Philadelphia, JB Lippincott, 1995, pp 361-383
25. Chiverton SG, Salena BJ, Burget DW, Hunt RH: Do hourly averaged pH readings correlate with those from point readings of aspiration? Comparison of two different electrode positions with simultaneous aspiration. Dig Dis 1:31-37, 1990
26. Isenberg JI, McQuaid KR, Laine L, Walsh JH: Acid-Peptic disorders. In Textbook of Gastroenterology. T Yamada (ed). Philadelphia, JB Lippincott, 1995, pp 1347-1430
27. Kopelman H, Corey M, Gaskin K, Durie P, Weizman Z, Forstner G: Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 95:349-355, 1988
28. Bovo P, Cataudella G, Di Francesco V, Vaona B, Filippini M, Marcori M, Montesi G, Rigo L, Frulloni L, Brunori MP, Andreaus MC, Cavallini G: Intraluminal gastric pH in chronic pancreatitis. Gut 36:294-298, 1995
29. Yeomans ND, Brimblecombe RW, Elder J, Heatley RV, Misiewicz JJ, Northfield TC, Pottage A: Effects of acid suppression on microbial flora of upper gut. Dig Dis Sci 40(suppl 2):81S-95S, 1995
30. Saltzman JR, Kowdley KV, Pedrosa MC, Sepe T, Golner B, Perrone G, Russell RM: Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 106:615-623, 1994
31. Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, Duroux P, Nicolet M, Pignatelli B, Blum AL, Gonvers JJ, Fried M: Bacterial overgrowth during treatment with omeprazole compared with cimetidine: A prospective randomised double blind study. Gut 39:54-59, 1996
32. Moore JG, Englert E: Circadian rhythm of gastric acid secretion in man. Nature 226:1261-1262, 1970
33. Cederberg C, Thomson AB, Mahachai V, Westin JA, Kirdeikis P, Fisher D, Zuk L, Marriage B: Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients. Gastroenterology 103:913-918, 1992
34. Coghlan JG, Humphries H, Dooley C, Keane C, Gilligan D, McKenna D, Sweeney E, O'Morain C: Campylobacter pylori and recurrence of duodenal ulcers - a 12-month follow-up study. Lancet 2:1109-1111, 1987
35. 13C]Urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis 157:777-780, 1988